A multiple-dose study evaluating the pharmacokinetics of 1200 mg once daily and 400 mg twice daily Raltegravir in healthy volunteers
Latest Information Update: 27 May 2017
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 27 May 2017 New trial record